The adaptation of human somatotropin and insulin assays to the automated Centria radioimmunoassay system [Clin. Chem. 21, 1305 (1975 and 5.1 tg/liter (Centria). Intra-and inter-run precision ranged from 3.2 to 15.9%. For the insulin assay, a phosphate/bovine serum albumin buffer (pH 7.4) is used, with a 20-h incubation at 4 #{176}C. Previously analyzed insulin samples from a reference laboratory were determined by the Centria analyzer with excellent correlation (r = 0.965). Means for patients' samples were 43.0 milli (USP) units of insulin per liter (reference laboratory) and 47.5 milliunits of insulin per liter (Centria). In both assays an anionicexchange gel is used in the separation step. The criterion of parallelism, an indication of the validity of a radioimmunoassay, was satisfied in both assays. The Centria radioimmunoassay system offers the advantage of automating all the critical steps of these radioimmunoassays.
the capacity to promote growth led to the development of specific bioassays for somatotropin (human growth hormone). Bioassays, while still necessary for accurate standardization of pure somatotropin preparations, are not sensitive enough to measure the very low concentrations of growth hormone present in biological fluids. An early observation (1) that mammalian growth hormones are species specific and thus capable of eliciting antibodies in other animals led to the development of radioimmunoassays for somatotropin (2) (3) (4) (5) . In fact, radioimmunoassays have become the method of choice for the measurement of a wide variety of molecules present in microgram or nanogram per liter concentrations in biological fluids ever since Yalow and Berson (6, 7) applied the technique to the determination of insulin concentrations.
Somatotropin radioimmunoassays have developed rapidly and are now being used in the detection and management of disorders that affect somatotropin secretion (8) .
Historically, automation in radioimmunoassay usually meant the use of automated counting equipment and the design of computer programs for data reduction. In recent years, it has become apparent that there is the need for automation in the other time-consuming steps, i.e., precise pipetting of reactants, control of incubation time and temperature, and separation of free from antibody-bound ligand.
Several systems evolved that automated certain aspects of the assay, but no system, until Centria, automated all the critical manual steps. In the mid nineteen-sixties, Pollard and Waldron (9) adapted an insulin radioimmunoassay to an instrument based on the continuous-flow technique. Its use was limited because of its mechanical complexity. Other systems have developed in which large numbers of test tubes, arranged in racks, are moved manually to allow the necessary operations of sample and reagent delivery, incubation, separation, and radioactive counting. Since certain assay manipulations are performed in a serial or sequential manner, there is always the possibility of variable incubation and separation times, a potentially serious problem in nonequilibrium assays. Marschner et al. (10) have described a system in which a unique filtering apparatus separates the second antibody complex from the free radioligand. Cottrell et al. (11) have developed a system in which incubation occurs with the antibody entrapped in a polyacrylamide gel. The gel is placed into a microcolumn; sample, standards and radioactive ligand are automatically added, and after the reaction is completed the free ligand is eluted from the gel. The assay is performed in a computerized system. This paper describes the adaptation of somatotropin and insulin radioimmunoassays to the Centria automated radioimmunoassay system. Our previously reported experiments (12) showed the adaptation of radioimmunoassays for some low-molecular-weight compounds-digoxin, triiodothyronine, and thyroxine-to a Centria analyzer, a column of Sephadex G-25 being used as the separation medium. The results reported in this paper describe the ready adaptation of somatotropin (molecular weight, 21 500) and insulin (molecular weight, 5800) radioimmunoassays to the Centria analyzer, with use of disposable plastic columns filled with an anionic exchange gel, diethylami-
noethyl-Sephadex
A-50, to separate antibody-bound and free ligand.
We describe the procedures for conducting the assays and compare the results with those obtained by manual methods in two other laboratories. The advantages that a Centria analyzer offers are the automation of all the critical steps of a radioimmunoassay and its ability to initiate and terminate immunoassays simultaneously.
Materials and Methods

Instrumentation
In the experiments described in this paper we used a laboratory prototype of the Centria radioimmunoassay system (Union Carbide Corp., Rye, N. Y. 10580). The system consists of three integrated modules: (a) an automated pipettor that dispenses accurate amounts of reagents and samples onto a plastic transfer disc where the incubations occur; (b) an incubator/separator, in which centrifugal force is used to initiate and terminate multiple radioassay incubations and separations simultaneously;
and (c) a gamma counter/computer, which counts radioactivity in three tubes simultaneously and converts these counts into concentration units. The system hardware has been described in a previous paper (12).
Reagents
Antisera. Anti-human somatotropin was elicited in young male New Zealand white rabbits. (13) . The three other injections were given intramuscularly, into the limbs. In all five boosting injections we used incomplete Freund's adjuvant (Difco Laboratories, Detroit, Mich. 48201; cat. No. 0639-60-6). The harvested anti-human somatotropin showed a titer (thefinal dilution of raw antiserum in the incubation mixture that will bind 50% of the radiolabeled antigen) of about 73 000.
Anti-insulin was prepared in young male guinea pigs (weighing 200-300 g each). As the immunogen we used "Iletin U-40" (a pork insulin), obtained from Eli Lilly & Co., Indianapolis, md. 46206. The anti-insulin (GP 68) we used in these experiments was harvested four months after the. primary injection of 10 USP units of insulin emulsified in Freund's complete adjuvant. During the four-month immunization schedule, the guinea pigs received three about equallyspaced booster injections of 10 units of insulin emulsified in adjuvant. Before each injection, the guinea pigs were given dex-
Abbott Laboratories, North Chicago, Ill. 60064) in their drinking water to prevent hypoglycemia. In several caseswhere the animals appeared to go into shock, they were given an intraperitoneal injection of dextrose (1 ml of a 500 g/liter dextrose solution). The harvested anti-insulin exhibited a titer of 420 000.
Radioactive Antigens '251-labeled somatotropin was obtained from Abbott Laboratories (lot No. GH-270) or prepared in our laboratory. The specific activities of the preparations were about 100 Ci/g. This material did not require purification either before or during use in the assays. The radioiodinated somatotropin was diluted so that about 40 pg were placed in each assay position. The radioiodinated somatotropin retained its immunochemical integrity, as evidenced by the relatively constant B0 (zero standard) observed over the course of the experiments and a standard curve that was responsive to increasing amounts of nonradiolabeled somatotropin. '251-labeled insulin was obtained from New England Nuclear, Boston, Mass. 02118, or prepared in our laboratory. Upon receipt, the '25I-labeled insulin was purified by passage through a Sephadex G-100 column, and did not need further purification during the course of the experiments. The specific activity of the iodinated insulin was about 180 Ci/g.
Standards
The somatotropin standard we used in these experiments was a gift from the National Pituitary Agency. The human insulin standard was purchased from Burroughs-Wellcome Co., Research Triangle Park, N. C. 27709.
Normal Human Serum
Both hormone standards were dissolved in "stripped" normal human serum, prepared by stirring 25 ml of pooled normal human serum with 3 g of charcoal ("Darco G-60"; Matheson, Coleman and Bell, Norwood, Ohio 45212) overnight at 4 #{176}C. The charcoal was then centrifuged at 10 000 rpm, and the supernatant fluid was first passed through conventional filter paper, then through 0.22 m (av pore size) filters (Millipore Corp., Fig. 1 . The Centria transfer disc treated with acetone and chromic acid before use; the diethylaminoethyl-Sephadex A-50 anionic exchange gel is a product of Pharmacia Fine Chemicals, Inc., Piscataway, N. J. 08854. The gel is allowed to swell overnight in a sodium phosphate buffer (0.2 mol/liter, pH 6.6) and is pipetted into the plastic columns to a height of 6 cm. The column diameter is 0.75 cm. Add 2.5 ml of After the transfer disc is loaded, incubation is begun for all the positions simultaneously by rotating the turntable at 120 rpm. This instantaneously mixes all reagents. Because the somatotropin and insulin assays have an incubation period of 20 h, the transfer disc is removed from the instrument after 5 mm of mixing, placed in a covered receptacle-i.e., an evaporating or crystallizing dish-and kept at 4 #{176}C. After the incubation time has elapsed, the disc is allowed to return to room temperature and is re-positioned on the incubator/separator module and accelerated to 220 rpm, which causes the incubated mixtures to be transferred onto the columns, where they are embedded into the separating medium. After an embedding time of 40 s, an eluent pump is activated, which transfers 50.4 ml of a 25 mmol/liter sodium phosphate buffer (pH 7.0) onto the spinning transfer disc. This eluting buffer is equally divided by the geometry of the transfer disc so that 1.4 ml of buffer is applied to each position. The antibodybound somatotropin or insulin is eluted into test tubes and subsequently counted and converted into concentration units by the counter/computer module. The incubation mixture from positions 35 and 36, which are used to determine total counts, is passed through a column that does not contain gel. liter. Values for somatotropin obtained by a reference laboratory were compared to values determined on Centria. The reference laboratory procedure involves a barbital/bovine serum albumin buffer, an incubation period of 3-5 days at 4 #{176}C, and dextran-coated charcoal in the separation step. The correlation curve is illustrated in Figure 3 . The regression equation was y = 1.122 x + 0.25 for 92 samples (y = Centria, x = reference laboratory), with a correlation coefficient of 0.930. The means for all 92 samples were 4.3 (reference laboratory) and 5.1 tg/liter (Centria). We collected further interand intra-assay precision data with a Centria analyzer, summarized in Table 2 . In the experiments reported in this paper, nonspecific binding-i.e., binding of the radiolabel in the absence of antibody-was never greater than 9%. Parallelism is one criterion for the validity of a radioimmunoassay (3, 14) . Experimentally, this criterion is satisfied if the radioimmunoassay standard curve (B/B0 vs. weight of cold antigen per milliliter) parallels or is superimposable on a second curve in which B/Bo vs. serial dilutions of a patient's serum sample are plotted. If the curve generated by the patient's sample does not parallel the radioimmunoassay standard curve, it indicates that there is not complete immunochemical identity between the patient's sample and the standards. Figure 4 shows the dose/response curve (somatotropin standard) and and by a reference laboratory for radioimmunoassay for somatotropin In order to linearize the experimental curves, we present the data as a logit-log transformation (14, 15) .
Insulin.
Tables 3 and 4 illustrate, respectively, the intra-and inter-assay precision data and analytical recovery studies 'for the insulin radioimmunoassay. 
Discussion
Although there have been efforts in the past to automate certain aspects of radioimmunoassay, the Centria analyzer represents the first completely integrated system for doing so. The overriding consideration was the design of an instrument that would automate all the critical manual steps in performing a radioimmunoassay, from the initial routine pipetting of reagents to the final generation of a standard curve and subsequent determination of clinical unknowns. The novel feature of the Centria system is its ability to begin and end radioassays simultaneously, allowing kinetic, nonequilibrium (and thus shorter) immunoassays to be done. Two types of gels have been adapted to the Centria system. For molecules of low molecular weight such as digoxin, triiodothyronine, and thyroxine, separation is easily achieved by using a column containing Sephadex G-25 (12). The Sephadex G-25, acting as a molecular sieve, slows passage of the small ligand while allowing the undissociated ligand/antibody complex to pass through the column virtually unretarded. For higher molecular weight compounds, such as somatotropin and insulin, a column of diethylaminoethyl-Sephadex A-50
replaced the Sephadex G-25. In this case, separation is achieved both by molecular sieving and ion-exchange. Ion-exchange separation has been used for a long time as a basic immunochemical technique for separation of gamma globulins from other contaminating proteins (17) . For the two immunoassays described in this paper, the following relationships exist between the isoelectric pH's (p1's) of the proteins and the pH of the eluting buffer. The p1's for somatotropin and anti-somatotropin are 6.9 and approximately 8.0, respectively. Thus, at the pH of the eluting buffer (7.0) there is little binding of the antibody to the ion-exchange medium. In the insulin assay, the following is seen. The p1's for insulin and anti-insulin are 5.4 and approximately 8.0, respectively. At the eluting buffer pH of 7.0, the insulin has a strong net negative charge and the anti-insulin shows a net positive charge. These charge differences allow for an excellent separation of free insulin from the antibodybound insulin on the anionic exchange gel. The low nonspecific binding (<9%) seen in both of these assays is a further indication of the suitability of diethylaminoethyl-Sephadex A-50 gel as a separation medium. As can be seen in Figures 3 and 6 , values for clinical samples obtained on Centria correlated well with those seen on using manual methods. It has also been observed that standard curves for both somatotropin and insulin exhibited a high degree of reproducibility. In practice, other experimental conditions could be used than those used in this paper. For example, the assay incubation time could be shortened if a lower sensitivity is acceptable. The convenience and simplicity of automation, as seen in the Centria system, promises to lead to an ever-increasing use of radioimmunoassay.
